149,471 members

Skip to content. | Skip to navigation

Commissioning of Palivizumab - To reduce the risk of RSV in high risk infants for the 2018 vaccination season

New Guidance - October 2018

Click on the file name to download it, or use the toolbox to upload a new version and/or examine the version history

PDF document icon SSC1937 - Commissioning of Palivizumab 2018.pdf — PDF document, 77 KB (79104 bytes)